4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000899243-21-031092
Chief Financial Officer bought 10,125 shares at $8.00 ($81,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Canepa John J Chief Financial Officer | 2021-07-29 | Purchase | +10,125 | $8.00 | $81,000 | 10,125 | D: show line 1 in the form |
| Open-market purchases · 10,125 sh · avg $8.00 · $81,000 | |||||||
Loading xslF345X03/doc4.xml…